CEACAM5 and gastric cancer: Early detection of gastric cancer (GC) remains challenging, as conventional protein-based biomarkers (e.g., CEA, CA72-4) exhibit low sensitivity and specificity, particularly in early-stage disease, underscoring the need for more reliable noninvasive diagnostic tools.